Citigroup’s Achaogen Inc AKAO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-17,540
| Closed | -$8K | – | 7958 |
|
|
2019
Q1 | $8K | Buy |
17,540
+7,384
| +73% | +$7.75K | ﹤0.01% | 7326 |
|
|
2018
Q4 | $12K | Sell |
10,156
-6,852
| -40% | -$18.3K | ﹤0.01% | 7105 |
|
|
2018
Q3 | $67K | Sell |
17,008
-80,607
| -83% | -$487K | ﹤0.01% | 6272 |
|
|
2018
Q2 | $845K | Sell |
97,615
-7,582
| -7% | -$92.4K | ﹤0.01% | 3543 |
|
|
2018
Q1 | $1.36M | Buy |
105,197
+12,248
| +13% | +$139K | ﹤0.01% | 2959 |
|
|
2017
Q4 | $998K | Buy |
92,949
+34,822
| +60% | +$437K | ﹤0.01% | 3340 |
|
|
2017
Q3 | $927K | Sell |
58,127
-5,330
| -8% | -$101K | ﹤0.01% | 3460 |
|
|
2017
Q2 | $1.38M | Buy |
63,457
+32,650
| +106% | +$745K | ﹤0.01% | 2975 |
|
|
2017
Q1 | $777K | Buy |
+30,807
| New | +$633K | ﹤0.01% | 3472 |
|
|
2016
Q2 | – | Sell |
-210
| Closed | -$1K | – | 7654 |
|
|
2016
Q1 | $1K | Buy |
+210
| New | +$816 | ﹤0.01% | 7376 |
|
|
2015
Q4 | – | Sell |
-49
| Closed | – | – | 8048 |
|
|
2015
Q3 | $0 | Buy |
49
+10
| +26% | +$68 | ﹤0.01% | 7960 |
|
|
2015
Q2 | $0 | Sell |
39
-339
| -90% | -$2.1K | ﹤0.01% | 7904 |
|
|
2015
Q1 | $4K | Sell |
378
-1,035
| -73% | -$11.7K | ﹤0.01% | 6816 |
|
|
2014
Q4 | $18K | Buy |
1,413
+1,173
| +489% | +$11.9K | ﹤0.01% | 6271 |
|
|
2014
Q3 | $2K | Buy |
240
+181
| +307% | +$1.85K | ﹤0.01% | 6844 |
|
|
2014
Q2 | $1K | Buy |
+59
| New | +$827 | ﹤0.01% | 7013 |
|
Other funds holding AKAO
NMC
GF
GI
SM
Citigroup's AKAO Position: Q2 2019 in Review
Citigroup sold out of Achaogen Inc (AKAO) in Q2 2019, closing a stake of 17,540 shares — an estimated $8K sold.
Citigroup first reported a position in AKAO in Q2 2014 and held it in 16 quarters. The position peaked at $1.38M in Q2 2017. 8 funds tracked by Wall St. Rank hold AKAO as of Q2 2019.
- Citigroup reported no remaining Achaogen Inc position as of Q2 2019 after selling out during the quarter.
- Citigroup sold 17,540 Achaogen Inc shares in Q2 2019, an estimated $8K.
- Citigroup first reported a position in Achaogen Inc in Q2 2014 and held it in 16 quarters.
- Citigroup's Achaogen Inc position peaked at $1.38M in Q2 2017.
- 8 funds tracked by Wall St. Rank held Achaogen Inc as of Q2 2019.
Based on Citigroup's 13F filing for Q2 2019, filed 12 Aug 2019.